In the case of progressive CLL patients, inhibition of the TGF-β pathway could be used to unblock the classical G0/G1 arrest in leukemic cells, and this action could be orchestrated by miR-26b-5p expression. This evidence concerns the gene TGFB1 and B-cell chronic lymphocytic leukemia.